Skip to Content

893 Results Found

  • Article
  • Open Access
6 Citations
4,136 Views
13 Pages

Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing—A Translational Example for Intensive Care Units

  • Ferdinand Anton Weinelt,
  • Miriam Songa Stegemann,
  • Anja Theloe,
  • Frieder Pfäfflin and ,
  • Stephan Achterberg,
  • Lisa Schmitt,
  • Wilhelm Huisinga,
  • Robin Michelet,
  • Stefanie Hennig and
  • Charlotte Kloft
  • + 5 authors+ 0 author

The prevalence and mortality rates of severe infections are high in intensive care units (ICUs). At the same time, the high pharmacokinetic variability observed in ICU patients increases the risk of inadequate antibiotic drug exposure. Therefore, dos...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Article
  • Open Access
17 Citations
4,588 Views
15 Pages

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

  • Laurynas Mockeliunas,
  • Lina Keutzer,
  • Marieke G. G. Sturkenboom,
  • Mathieu S. Bolhuis and ,
  • Lotte M. G. Hulskotte,
  • Onno W. Akkerman and
  • Ulrika S. H. Simonsson
  • + 2 authors+ 0 author

Linezolid is an efficacious medication for the treatment of drug-resistant tuberculosis but has been associated with serious safety issues that can result in treatment interruption. The objectives of this study were thus to build a population pharmac...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Review
  • Open Access
13 Citations
6,917 Views
18 Pages

The appropriate use of antibiotics is crucial and involves selecting an optimal dosing regimen based on pharmacokinetic (PK) and pharmacodynamic (PD) indicators. Physiologically based pharmacokinetic (PBPK) modeling is a powerful tool that integrates...

(This article belongs to the Special Issue Clinical Pharmacokinetics, Pharmacodynamics, and/or TDM of Antimicrobial Agents)
  • Review
  • Open Access
40 Citations
8,052 Views
15 Pages

Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review

  • Paula Del Valle-Moreno,
  • Paloma Suarez-Casillas,
  • Marta Mejías-Trueba,
  • Pablo Ciudad-Gutiérrez and ,
  • Ana Belén Guisado-Gil,
  • María Victoria Gil-Navarro and
  • Laura Herrera-Hidalgo
  • + 2 authors+ 0 author

Background: Pharmacokinetic nomograms, equations, and software are considered the main tools available for Therapeutic Drug Monitoring (TDM). Model-informed precision dosing (MIPD) is an advanced discipline of TDM that allows dose individualization,...

(This article belongs to the Special Issue Therapeutic Drug Monitoring)
  • Article
  • Open Access
2 Citations
1,864 Views
12 Pages

14 January 2026

Background: Tobramycin is a key therapy for pulmonary exacerbations in children and adolescents with cystic fibrosis (CF), yet its variable pharmacokinetics (PK) combined with narrow therapeutic index necessitates therapeutic drug monitoring (TDM) du...

(This article belongs to the Special Issue Pediatric Drug Therapy: Safety, Efficacy, and Personalized Medicine)
  • Review
  • Open Access
763 Views
32 Pages

Narrow Therapeutic Index Drugs: Regulatory Frameworks, Bioequivalence, and Model-Informed Precision Dosing

  • Mengmeng Liu,
  • Zhe Wang,
  • Yongbo Chen,
  • Yuqi Jia and ,
  • Lei Xu,
  • Haojie Xu,
  • Jueyu Li and
  • Libo Zhao
  • + 3 authors+ 0 author

Background/Objectives: Narrow therapeutic index (NTI) drugs are characterized by a small margin between effective and toxic exposure. This review aimed to summarize international definitions and regulatory frameworks for NTI drugs, compare bioequival...

(This article belongs to the Special Issue Therapeutic Drug Monitoring as a Useful Tool in Therapy Improvement, 3rd Edition)
  • Systematic Review
  • Open Access
2 Citations
1,253 Views
11 Pages

15 May 2026

Background: Bayesian model-informed precision dosing (MIPD) is increasingly used to individualize drug therapy; therefore, this review aimed to identify and characterize its implementation in routine clinical practice. Methods: A focused systematic r...

(This article belongs to the Special Issue Recent Advances in Clinical Pharmacology Based on Pharmacokinetics)
  • Review
  • Open Access
578 Views
29 Pages

Background/Objectives: Busulfan is a cornerstone conditioning agent for pediatric hematopoietic stem cell transplantation (HSCT), yet its narrow therapeutic index and substantial pharmacokinetic (PK) variability complicate dosing. This review synthes...

(This article belongs to the Special Issue Model-Informed Precision Dosing in Drug Development and Clinical Practice)
  • Article
  • Open Access
10 Citations
4,219 Views
11 Pages

Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis

  • Ruben Faelens,
  • Zhigang Wang,
  • Thomas Bouillon,
  • Paul Declerck and ,
  • Marc Ferrante,
  • Séverine Vermeire and
  • Erwin Dreesen
  • + 2 authors+ 0 author

Model-informed precision dosing (MIPD) may be a solution to therapeutic failure of infliximab for patients with ulcerative colitis (UC), as underexposure could be avoided, and the probability of endoscopic improvement (pEI; Mayo endoscopic subscore ≤...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Article
  • Open Access
2 Citations
3,036 Views
16 Pages

Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial

  • Sarah Dräger,
  • Tim M. J. Ewoldt,
  • Alan Abdulla,
  • Wim J. R. Rietdijk and ,
  • Nelianne Verkaik,
  • Christian Ramakers,
  • Evelien de Jong,
  • Michael Osthoff,
  • Birgit C. P. Koch and
  • Henrik Endeman
  • + 5 authors+ 0 author

Model-informed precision dosing (MIPD) might be used to optimize antibiotic treatment. Procalcitonin (PCT) is a biomarker for severity of infection and response to antibiotic treatment. The aim of this study was to assess the impact of MIPD on the co...

(This article belongs to the Special Issue Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine)
  • Review
  • Open Access
6 Citations
3,304 Views
13 Pages

Model-Informed Precision Dosing: Conceptual Framework for Therapeutic Drug Monitoring Integrating Machine Learning and Artificial Intelligence Within Population Health Informatics

  • Jennifer Le,
  • Hien N. Le,
  • Giang Nguyen,
  • Rebecca Kim and ,
  • Sean N. Avedissian,
  • Connie Vo,
  • Ba Hai Le,
  • Thanh Hai Nguyen,
  • Dua Thi Nguyen and
  • Amy M. Sitapati
  • + 12 authors+ 7 authors

31 January 2026

Background/Objective: Traditional therapeutic drug monitoring is limited by manual interpretation and specific constraints like sampling at steady-state and requiring a minimum of two drug concentrations. The integration of model-informed precision d...

(This article belongs to the Special Issue Artificial Intelligence for Personalized Medicine: Bridging Innovative Technologies and Patient-Centric Care)
  • Review
  • Open Access
149 Citations
13,981 Views
27 Pages

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

  • Kazuaki Matsumoto,
  • Kazutaka Oda,
  • Kensuke Shoji,
  • Yuki Hanai and ,
  • Yoshiko Takahashi,
  • Satoshi Fujii,
  • Yukihiro Hamada,
  • Toshimi Kimura,
  • Toshihiko Mayumi and
  • Yoshio Takesue
  • + 7 authors+ 2 authors

Background: To promote model-informed precision dosing (MIPD) for vancomycin (VCM), we developed statements for therapeutic drug monitoring (TDM). Methods: Ten clinical questions were selected. The committee conducted a systematic review and meta-ana...

(This article belongs to the Special Issue Therapeutic Drug Monitoring as a Useful Tool in Therapy Improvement)
  • Article
  • Open Access
17 Citations
5,295 Views
16 Pages

Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?

  • Letao Li,
  • Sebastiaan D. T. Sassen,
  • Tim M. J. Ewoldt,
  • Alan Abdulla and ,
  • Nicole G. M. Hunfeld,
  • Anouk E. Muller,
  • Brenda C. M. de Winter,
  • Henrik Endeman and
  • Birgit C. P. Koch
  • + 4 authors+ 0 author

13 February 2023

The number of pharmacokinetic (PK) models of meropenem is increasing. However, the daily role of these PK models in the clinic remains unclear, especially for critically ill patients. Therefore, we evaluated the published meropenem models on real-wor...

(This article belongs to the Special Issue Therapeutic Drug Monitoring in Intensive Care)
  • Editorial
  • Open Access
46 Citations
6,137 Views
4 Pages

Model-Informed Precision Dosing (MIPD)

  • Jonás Samuel Pérez-Blanco and
  • José M. Lanao

Model-informed precision dosing (MIPD) is an advanced quantitative approach focusing on individualized dosage optimization, integrating complex mathematical and statistical models of drugs and disease combined with individual demographic and clinical...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Article
  • Open Access
5 Citations
2,792 Views
15 Pages

Model-Informed Precision Dosing for Personalized Ustekinumab Treatment in Plaque Psoriasis

  • Karine Rodríguez-Fernández,
  • Javier Zarzoso-Foj,
  • Marina Saez-Bello,
  • Almudena Mateu-Puchades and ,
  • Antonio Martorell-Calatayud,
  • Matilde Merino-Sanjuan,
  • Elena Gras-Colomer,
  • Monica Climente-Martí and
  • Victor Mangas-Sanjuan
  • + 4 authors+ 0 author

Background/Objectives: Implementing model-informed precision dosing (MIPD) strategies guided by population pharmacokinetic/pharmacodynamic (PK/PD) models could enhance the management of inflammatory diseases such as psoriasis. However, the extent of...

(This article belongs to the Special Issue Population Pharmacokinetics and Its Clinical Applications)
  • Article
  • Open Access
1 Citations
1,808 Views
16 Pages

Population Pharmacokinetics and Model-Informed Dose Optimization of Teicoplanin in Adults with Hematological Malignancies

  • María García-Hervalejo,
  • José Germán Sánchez-Hernández,
  • Irene Conde-González,
  • Alejandro Avendaño Pita and
  • María José Otero

Background: Teicoplanin is widely used for the empirical and targeted treatment of febrile neutropenia in patients with hematological malignancies. However, the pathophysiological alterations typical of this population may substantially affect drug e...

(This article belongs to the Special Issue Model-Informed Precision Dosing in Drug Development and Clinical Practice)
  • Review
  • Open Access
2 Citations
1,400 Views
32 Pages

Advancing Pediatric Dose Scaling: Strategies, Modeling Approaches, and Clinical Applications

  • Rachel A. Kudgus Lokken,
  • Sílvia M. Illamola,
  • Kathleen M. Job,
  • Hesham S. Al-Sallami and ,
  • Geert W. ‘t Jong,
  • David M. Reith,
  • Angela K. Birnbaum and
  • Catherine M. Sherwin
  • + 3 authors+ 0 author

15 July 2026

Background/Objectives: Selecting appropriate doses for pediatric patients remains one of the most complex challenges in drug development because developmental changes in physiology, metabolism, organ function, and pharmacodynamics substantially influ...

(This article belongs to the Special Issue Pediatric Drug Therapy: Safety, Efficacy, and Personalized Medicine)
  • Article
  • Open Access
2 Citations
2,941 Views
16 Pages

Personalized Secukinumab Treatment in Patients with Plaque Psoriasis Using Model-Informed Precision Dosing

  • Karine Rodriguez-Fernandez,
  • Javier Zarzoso-Foj,
  • Marina Saez-Bello,
  • Almudena Mateu-Puchades and ,
  • Antonio Martorell-Calatayud,
  • Matilde Merino-Sanjuan,
  • Elena Gras-Colomer,
  • Monica Climente-Marti and
  • Victor Mangas-Sanjuan
  • + 4 authors+ 0 author

Background/Objectives: Patient care and control of inflammatory disorders, such as psoriasis, can be improved by model-informed precision dosing (MIPD) techniques based on population pharmacokinetic/pharmacodynamic (PK/PD) models. Clinical dose selec...

(This article belongs to the Special Issue Population Pharmacokinetics and Its Clinical Applications)
  • Article
  • Open Access
12 Citations
3,887 Views
19 Pages

Repurposing of remdesivir and other drugs with potential antiviral activity has been the basis of numerous clinical trials aimed at SARS-CoV-2 infection in adults. However, expeditiously designed trials without careful consideration of dose rationale...

(This article belongs to the Special Issue The Role of Pharmacometrics in Drug Discovery and Development Process)
  • Review
  • Open Access
1 Citations
1,107 Views
24 Pages

Mechanistic Artificial Intelligence for Personalized Drug Therapy: Integrating Pharmacokinetics, Pharmacodynamics, Therapeutic Drug Monitoring, and Multiomic Systems Biology

  • Ian Jenkins,
  • Krista Casazza,
  • Waldemar Lernhardt,
  • Valentina Savich and ,
  • Jayson Uffens,
  • Vaishnavi Narayan and
  • Jonathan R. T. Lakey
  • + 2 authors+ 0 author

Interindividual variability in drug response remains a major challenge in clinical pharmacology despite substantial advances in therapeutic drug monitoring (TDM), pharmacogenomics, pharmacokinetics/pharmacodynamics (PK/PD), and model-informed precisi...

(This article belongs to the Special Issue Personalized Drug Therapy: The Role of Pharmacokinetics and Therapeutic Drug Monitoring, 2nd Edition)
  • Review
  • Open Access
796 Views
28 Pages

Drug Dosing During Continuous Renal Replacement Therapy in Critically Ill Patients: A Practical Narrative Review

  • Mihai Claudiu Pui,
  • Alexandra Elena Lazar,
  • Janos Szederjesi,
  • Oana Elena Branea and ,
  • Mihaela Butiulca,
  • Vlad-Dimitrie Cehan,
  • Mihaela Straistă and
  • Leonard Azamfirei
  • + 3 authors+ 0 author

Drug dosing during continuous renal replacement therapy (CRRT) is difficult in critically ill patients because drug exposure is influenced by both the patient and the extracorporeal treatment. This narrative review provides a practical overview of dr...

(This article belongs to the Special Issue Optimizing Drug Therapy Through Pharmacokinetics and Therapeutic Drug Monitoring)
  • Article
  • Open Access
1,846 Views
15 Pages

Background/Objective: Voriconazole exhibits nonlinear pharmacokinetics and wide interindividual variability driven by CYP2C19 phenotype and clinical covariates, necessitating early therapeutic drug monitoring (TDM). This study aimed to assess how the...

(This article belongs to the Special Issue Population Pharmacokinetics: Where Are We Now?)
  • Article
  • Open Access
13 Citations
3,205 Views
20 Pages

Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir

  • Wenyu Yang,
  • Wenyao Mak,
  • Amanda Gwee,
  • Meng Gu and ,
  • Yue Wu,
  • Yufei Shi,
  • Qingfeng He,
  • Xiaoqiang Xiang,
  • Bing Han and
  • Xiao Zhu
  • + 5 authors+ 0 author

Background: Ganciclovir and valganciclovir are used for prophylaxis and treatment of cytomegalovirus infection. However, there is great interindividual variability in ganciclovir’s pharmacokinetics (PK), highlighting the importance of individua...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Review
  • Open Access
12 Citations
5,607 Views
13 Pages

Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates

  • Mario Regazzi,
  • Alberto Berardi,
  • Simonetta Picone and
  • Chryssoula Tzialla

18 December 2023

The selection of an appropriate dose of a given antibiotic for a neonate not only requires knowledge of the drug’s basic pharmacokinetic (PK) and pharmacodynamic (PD) properties but also the profound effects that organ development might have on...

  • Article
  • Open Access
21 Citations
4,992 Views
21 Pages

External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease

  • Christina Schräpel,
  • Lukas Kovar,
  • Dominik Selzer,
  • Ute Hofmann and ,
  • Florian Tran,
  • Walter Reinisch,
  • Matthias Schwab and
  • Thorsten Lehr
  • + 3 authors+ 0 author

Infliximab is approved for treatment of various chronic inflammatory diseases including inflammatory bowel disease (IBD). However, high variability in infliximab trough levels has been associated with diverse response rates. Model-informed precision...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Article
  • Open Access
16 Citations
3,632 Views
11 Pages

Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin

  • Justine Heitzmann,
  • Yann Thoma,
  • Romain Bricca,
  • Marie-Claude Gagnieu and ,
  • Vincent Leclerc,
  • Sandrine Roux,
  • Anne Conrad,
  • Tristan Ferry and
  • Sylvain Goutelle
  • + 4 authors+ 0 author

Daptomycin is a candidate for therapeutic drug monitoring (TDM). The objectives of this work were to implement and compare two pharmacometric tools for daptomycin TDM and precision dosing. A nonparametric population PK model developed from patients w...

(This article belongs to the Special Issue Innovative Tools for Therapeutic Drug Monitoring)
  • Article
  • Open Access
2 Citations
3,377 Views
13 Pages

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups

  • Anna Mueller-Schoell,
  • Robin Michelet,
  • Lena Klopp-Schulze,
  • Madelé van Dyk and ,
  • Thomas E. Mürdter,
  • Matthias Schwab,
  • Markus Joerger,
  • Wilhelm Huisinga,
  • Gerd Mikus and
  • Charlotte Kloft
  • + 5 authors+ 0 author

18 May 2021

Tamoxifen is used worldwide to treat estrogen receptor-positive breast cancer. It is extensively metabolized, and minimum steady-state concentrations of its metabolite endoxifen (CSS,min ENDX) >5.97 ng/mL have been associated with favorable outcom...

(This article belongs to the Special Issue Pharmacokinetics/Pharmacodynamics/Pharmacogenetics Based Personalized Medicine for Cancer Therapy)
  • Article
  • Open Access
4 Citations
4,197 Views
18 Pages

A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule

  • Iraj Hosseini,
  • Brett Fleisher,
  • Jennifer Getz,
  • Jérémie Decalf and ,
  • Mandy Kwong,
  • Meric Ovacik,
  • Travis W. Bainbridge,
  • Christine Moussion,
  • Gautham K. Rao and
  • Saroja Ramanujan
  • + 7 authors+ 2 authors

FLT3L-Fc is a half-life extended, effectorless Fc-fusion of the native human FLT3-ligand. In cynomolgus monkeys, treatment with FLT3L-Fc leads to a complex pharmacokinetic/pharmacodynamic (PK/PD) relationship, with observed nonlinear PK and expansion...

(This article belongs to the Special Issue Role of Pharmacokinetics in Drug Development and Evaluation)
  • Review
  • Open Access
18 Citations
5,174 Views
23 Pages

Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management

  • Rannissa Puspita Jayanti,
  • Nguyen Phuoc Long,
  • Nguyen Ky Phat,
  • Yong-Soon Cho and
  • Jae-Gook Shin

Standard tuberculosis (TB) management has failed to control the growing number of drug-resistant TB cases worldwide. Therefore, innovative approaches are required to eradicate TB. Model-informed precision dosing and therapeutic drug monitoring (TDM)...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Perspective
  • Open Access
10 Citations
10,711 Views
14 Pages

22 November 2021

Pharmacokinetics (PK) is a branch of pharmacology present and of vital importance for the research and development (R&D) of new drugs, post-market monitoring, and continued optimizations in clinical contexts. Ultimately, pharmacokinetics can cont...

(This article belongs to the Special Issue Studies of the Dosage Form and Stability of the Drug by Various Techniques)
  • Article
  • Open Access
2 Citations
2,875 Views
10 Pages

Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis

  • Jérémy Reverchon,
  • Vianney Tuloup,
  • Romain Garreau,
  • Viviane Nave and ,
  • Sabine Cohen,
  • Philippe Reix,
  • Stéphane Durupt,
  • Raphaele Nove-Josserand,
  • Isabelle Durieu and
  • Sylvain Goutelle
  • + 8 authors+ 3 authors

Therapeutic drug monitoring (TDM) of tobramycin is widely performed in patients with cystic fibrosis (CF), but little is known about the value of model-informed precision dosing (MIPD) in this setting. We aim at reporting our experience with tobramyc...

(This article belongs to the Special Issue Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy)
  • Article
  • Open Access
521 Views
17 Pages

UHPLC-UV Method for Vancomycin Quantification in Human Plasma by Simple Protein Precipitation: Development and Validation for Therapeutic Drug Monitoring

  • Joanne Palomino Saavedra,
  • Yina Pájaro González,
  • Donaldo de la Hoz Santander,
  • Edwin Enrique Tenorio Jiménez and ,
  • Orison Hernández Gámez and
  • Gina Paola Domínguez Moré
  • + 1 author+ 0 author

19 September 2026

Vancomycin (VCN) is a glycopeptide antibiotic widely used to treat Gram-positive infections such as those caused by methicillin-resistant Staphylococcus aureus (MRSA). Its narrow therapeutic window, high interindividual pharmacokinetic variability, a...

  • Article
  • Open Access
10 Citations
3,178 Views
13 Pages

Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children

  • Sylvain Goutelle,
  • Yann Thoma,
  • Roxane Buffet,
  • Michael Philippe and ,
  • Thierry Buclin,
  • Monia Guidi and
  • Chantal Csajka
  • + 2 authors+ 0 author

Busulfan, a drug used in conditioning prior to hematopoietic stem cell transplantation (HSCT) in children, has a narrow therapeutic margin. The model-informed precision dosing (MIPD) of busulfan is desirable, but there is a lack of validated tools. T...

(This article belongs to the Special Issue Population Pharmacokinetics in Oncology and Its Clinical Applications)
  • Review
  • Open Access
171 Views
44 Pages

Hydroxyurea Pharmacokinetics and Precision Dosing in Sickle Cell Disease: A Scoping Review

  • Amna Mohamed,
  • Jokha Al-Qassabi,
  • Bushra Salman and
  • Khaled Abduljalil

8 November 2026

Background: Hydroxyurea is the cornerstone disease-modifying therapy for sickle cell disease (SCD), but interindividual pharmacokinetic (PK) variability contributes to differences in drug exposure and treatment response. This scoping review synthesis...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
5 Citations
4,586 Views
11 Pages

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies

  • Anna Mueller-Schoell,
  • Lena Klopp-Schulze,
  • Robin Michelet,
  • Madelé van Dyk and ,
  • Thomas E. Mürdter,
  • Matthias Schwab,
  • Markus Joerger,
  • Wilhelm Huisinga,
  • Gerd Mikus and
  • Charlotte Kloft
  • + 5 authors+ 0 author

3 February 2021

Tamoxifen is widely used in breast cancer treatment and minimum steady-state concentrations of its active metabolite endoxifen (CSS,min ENDX) above 5.97 ng/mL have been associated with favourable disease outcome. Yet, about 20% of patients do not rea...

(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)
  • Feature Paper
  • Article
  • Open Access
187 Views
24 Pages

Objective: We aimed to develop and evaluate population pharmacokinetic (PopPK) models of atomoxetine incorporating clinically available patient information and to explore model-informed dose selection in Chinese children and adolescents with attentio...

(This article belongs to the Special Issue Personalized Drug Therapy: The Role of Pharmacokinetics and Therapeutic Drug Monitoring, 2nd Edition)
  • Article
  • Open Access
15 Citations
4,936 Views
14 Pages

Background: Methotrexate (MTX) is a key immunosuppressant for children with acute lymphoid leukemia (ALL), and it has a narrow therapeutic window and relatively high pharmacokinetic variability. Several population pharmacokinetic (PopPK) models of MT...

(This article belongs to the Special Issue Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy)
  • Article
  • Open Access
2 Citations
4,011 Views
19 Pages

Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin

  • Gellért Balázs Karvaly,
  • István Vincze,
  • Michael Noel Neely,
  • István Zátroch and ,
  • Zsuzsanna Nagy,
  • Ibolya Kocsis and
  • Csaba Kopitkó
  • + 2 authors+ 0 author

Population pharmacokinetic (pop-PK) models constructed for model-informed precision dosing often have limited utility due to the low number of patients recruited. To augment such models, an approach is presented for generating fully artificial quasi-...

(This article belongs to the Special Issue Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy)
  • Article
  • Open Access
15 Citations
3,413 Views
10 Pages

Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases

  • Christian Primas,
  • Walter Reinisch,
  • John C. Panetta,
  • Alexander Eser and ,
  • Diane R. Mould and
  • Thierry Dervieux
  • + 1 author+ 0 author

9 June 2022

Background: Substantial inter-and intra-individual variability of Infliximab (IFX) pharmacokinetics necessitates tailored dosing approaches. Here, we evaluated the performances of a Model Informed Precision Dosing (MIPD) Tool in forecasting trough In...

(This article belongs to the Special Issue New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases)
  • Article
  • Open Access
1,732 Views
16 Pages

PopPK and PBPK Models Guide Meropenem Dosing in Critically Ill Children with Augmented Renal Clearance

  • Yao Liu,
  • Hua He,
  • Sa-Sa Zhang,
  • Jia Zhou and ,
  • Jin-Wei Zhu,
  • Jin Xu,
  • Hong-Jun Miao,
  • Ji-Hui Chen and
  • Kun Hao
  • + 4 authors+ 0 author

Background: Meropenem (MEM) is frequently prescribed for the empirical management of severe infections in the pediatric intensive care unit (PICU). Critically ill children exhibit substantial pharmacokinetic (PK) variability, and current dosing strat...

(This article belongs to the Special Issue Development of Physiologically Based Pharmacokinetic (PBPK) Modeling)
  • Article
  • Open Access
1 Citations
1,377 Views
15 Pages

Background: Staphylococcal bloodstream infections (BSIs) and infective endocarditis (IE) are associated with high morbidity and mortality. Among the different antimicrobial combination strategies proposed to enhance antibacterial activity, the associ...

(This article belongs to the Section Antibiotics Use and Antimicrobial Stewardship)
  • Review
  • Open Access
3,310 Views
29 Pages

Ketamine in Diabetes Care: Metabolic Insights and Clinical Applications

  • Shiryn D. Sukhram,
  • Majandra Sanchez,
  • Ayotunde Anidugbe,
  • Bora Kupa and ,
  • Vincent P. Edwards,
  • Muhammad Zia and
  • Grozdena Yilmaz
  • + 2 authors+ 0 author

Background: Depression and diabetic neuropathy (DN) commonly complicate diabetes and impair glycemic control and quality of life. Ketamine and its S-enantiomer, esketamine, provide rapid antidepressant and analgesic effects, yet diabetes-related path...

(This article belongs to the Special Issue Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and Applications)
  • Systematic Review
  • Open Access
207 Views
28 Pages

Background/Objectives: Voriconazole dosing in children is complicated by developmental and nonlinear pharmacokinetics, cytochrome P450 2C19 (CYP2C19) variation, variable oral bioavailability, inflammation, organ dysfunction, and drug interactions. We...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Article
  • Open Access
10 Citations
3,285 Views
12 Pages

Remimazolam, widely used for procedural sedation and general anesthesia, is a new ultra short-acting benzodiazepine for intravenous sedation and anesthesia. We aim to characterize the pharmacokinetics/pharmacodynamics (PK/PD) of remimazolam and its m...

(This article belongs to the Special Issue Mechanism-Based Pharmacokinetic and Pharmacodynamic Modeling)
  • Article
  • Open Access
9 Citations
3,411 Views
12 Pages

Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing

  • Warit Ruanglertboon,
  • Michael J. Sorich,
  • Ashley M. Hopkins and
  • Andrew Rowland

21 April 2021

The primary objective of this study is to evaluate the capacity of concentration-guided sorafenib dosing protocols to increase the proportion of patients that achieve a sorafenib maximal concentration (Cmax) within the range 4.78 to 5.78 μg/mL. A ful...

(This article belongs to the Special Issue Anticancer Drugs 2021)
  • Article
  • Open Access
9 Citations
2,995 Views
11 Pages

Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients

  • Simon Kallee,
  • Christina Scharf,
  • Lea Marie Schatz,
  • Michael Paal and ,
  • Michael Vogeser,
  • Michael Irlbeck,
  • Johannes Zander,
  • Michael Zoller and
  • Uwe Liebchen
  • + 4 authors+ 0 author

Voriconazole (VRC) is used as first line antifungal agent against invasive aspergillosis. Model-based approaches might optimize VRC therapy. This study aimed to investigate the predictive performance of pharmacokinetic models of VRC without pharmacog...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Article
  • Open Access
3 Citations
1,910 Views
19 Pages

Population Pharmacokinetics and Model-Informed Precision Dosing of Clobazam Based on the Developmental and Genetic Characteristics of Children with Epilepsy

  • Yali Tuo,
  • Xiaolong Yu,
  • Sichan Li,
  • Jun Wang and ,
  • Maochang Liu,
  • Xinwen Song,
  • Jiehui Ma,
  • Yang Wang,
  • Zhisheng Liu and
  • Dan Sun
  • + 5 authors+ 0 author

Background/Objectives: This study aimed to characterize the pharmacokinetic profiles of clobazam (CLB) and its active metabolite, N-desmethylclobazam (N-CLB), by establishing a population pharmacokinetic (PPK) model in Chinese children with epilepsy...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Article
  • Open Access
23 Citations
10,913 Views
18 Pages

Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions

  • Simeon Rüdesheim,
  • Jan-Georg Wojtyniak,
  • Dominik Selzer,
  • Nina Hanke and ,
  • Felix Mahfoud,
  • Matthias Schwab and
  • Thorsten Lehr
  • + 2 authors+ 0 author

The beta-blocker metoprolol (the sixth most commonly prescribed drug in the USA in 2017) is subject to considerable drug–gene interaction (DGI) effects caused by genetic variations of the CYP2D6 gene. CYP2D6 poor metabolizers (5.7% of US popula...

(This article belongs to the Special Issue Applications of Physiologically-Based Pharmacokinetic (PBPK) Modeling)
  • Article
  • Open Access
14 Citations
8,499 Views
13 Pages

Evaluation of Current Amikacin Dosing Recommendations and Development of an Interactive Nomogram: The Role of Albumin

  • Jonás Samuel Pérez-Blanco,
  • Eva María Sáez Fernández,
  • María Victoria Calvo,
  • José M. Lanao and
  • Ana Martín-Suárez

This study aimed to evaluate the potential efficacy and safety of the amikacin dosage proposed by the main guidelines and to develop an interactive nomogram, especially focused on the potential impact of albumin on initial dosage recommendation. The...

(This article belongs to the Special Issue The Role of Pharmacometrics in Drug Discovery and Development Process)
  • Article
  • Open Access
1,303 Views
13 Pages

Risk of Potentially Neurotoxic Exposure in Infants Under High-Dose Cefepime Treatment—A Pharmacometric Simulation Study

  • Verena Gotta,
  • Chantal Csajka,
  • Antonia Glauser,
  • Christoph Berger and ,
  • Marc Pfister and
  • Paolo Paioni
  • + 1 author+ 0 author

Background: Optimal dosing of cefepime in infants 1–2 months remains undefined. Objectives: We aimed to quantify the risk of potentially neurotoxic exposure with high-dose cefepime (50 mg/kg/8 h) in infants 1–2 months of age, as compared...

(This article belongs to the Special Issue Precision Dosing in Clinical Therapeutics: The Application of Pharmacokinetics and Pharmacometrics)

of 18